Emerging checkpoints like LAG-3 play a pivotal role in downregulating T-cell activation, and their expression has been associated with poor prognosis in various malignancies, including renal clear cell carcinoma (KIRC) and kidney renal papillary cell carcinoma (KIRP) [128,129]. Here, LAG3 is linked to clear cell renal carcinoma.